Evidence map›Paper›PMID 32501218›Full record

ReviewPlacenta2020

Factors preventing materno-fetal transmission of SARS-CoV-2.

Onder Celik, Aylin Saglam, Bora Baysal, Iris E Derwig, Nilufer Celik, Mehmet Ak, Selma N Aslan, Mustafa Ulas, Aynur Ersahin, Ahter T Tayyar and 2 more

Open access · greenAbstract readReview
In one paragraph

Review in Placenta, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. COVID-19 in pregnancy: What we know from the first year of the pandemic.Biochimica et biophysica acta. Molecular basis of disease · 2021
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Onder CelikPrivate Clinic Obstetrics and Gynecology, Usak, Turkey. Electronic address: celiksudenaz@gmail.com.
Aylin SaglamDepartment of Obstetrics and Gynecology, Aksaray University School of Medicine, Aksaray, Turkey.
Bora BaysalDepartment of Neonatology, Faculty of Medicine Usak University, Usak, Turkey.
Iris E DerwigChelsea Westminster Hospital NHS Foundation Trust, London, England, UK.
Nilufer CelikDepartment of Biochemistry, Dr. Behcet Uz Children's Research and Training Hospital, Izmir, Turkey.
Mehmet AkDepartment of Obstetrics and Gynecology, Kayseri City Hospital, Kayseri, Turkey.
Selma N AslanGazi University, Faculty of Pharmacy, Toxicology Department, Ankara, Turkey.
Mustafa UlasDepartment of Physiology, Firat University School of Medicine, Elazig, Turkey.
Aynur ErsahinDepartment of Obstetrics and Gynecology, Bahcesehir University School of Medicine, Istanbul, Turkey.
Ahter T TayyarDepartment of Obstetrics and Gynecology, Bahcesehir University School of Medicine, Istanbul, Turkey.
Bulent DuranDepartment of Obstetrics and Gynecology, Adatıp Hospital, Sakarya, Turkey.
Suleyman AydinDepartment of Medical Biochemistry, Firat University School of Medicine, Elazig, Turkey.
Bahçeşehir University · TRFırat University · TRUsak University · TRAksaray University · TRChelsea and Westminster Hospital NHS Foundation Trust · GBDr. Behçet Uz Çocuk Hastalıkları Hastanesi · TRGazi University · TRKayseri Eğitim ve Araştırma Hastanesi · TRSakarya Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although many pregnant women have been infected by coronavirus, the presence of intrauterine vertical transmission has not been conclusively reported yet. What prevents this highly contagious virus from reaching the fetus? Is it only the presence of a strong placental barrier, or is it the natural absence of the some receptor that the viruses use for transmission? We, therefore, need to comprehensively understand the mechanism of action of the mammalian epithelial barriers located in two different organs with functional similarity. The barriers selected as potential targets by SARS-CoV-2 are the alveolo-capillary barrier (ACB), and the syncytio-capillary barrier (SCB). Caveolae are omega-shaped structures located on the cell membrane. They consist of caveolin-1 protein (Cav-1) and are involved in the internalisation of some viruses. By activating leukocytes and nuclear factor-κB, Cav-1 initiates inflammatory reactions. The presence of more than one Cav-1 binding sites on coronavirus is an important finding supporting the possible relationship between SARS-CoV-2-mediated lung injury. While the ACB cells express Cav-1 there is no caveolin expression in syncytiotrophoblasts. In this short review, we will try to explain our hypothesis that the lack of caveolin expression in the SCB is one of the most important physiological mechanisms that prevents vertical transmission of SARS-CoV-2. Since the physiological Cav-1 deficiency appears to prevent acute cell damage treatment algorithms could potentially be developed to block this pathway in the non-pregnant population affected by SARS-CoV-2.

Indexed as

BetacoronavirusCaveolin 1Coronavirus InfectionsCOVID-19EpitheliumFemaleFetal DiseasesGiant CellsHumansImmunity, InnateInfectious Disease Transmission, VerticalMaternal-Fetal ExchangePandemicsPneumonia, ViralPregnancyRisk FactorsCaveolin 1CaveolinEpithelial barrierLungPlacentaSARS-CoV-2Syncytium

Identifiers

PMID32501218
PMCPMC7258816
OpenAlexW3029869111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.